Literature DB >> 8275465

Distinct deletions of chromosome 9p associated with melanoma versus glioma, lung cancer, and leukemia.

A Coleman1, J W Fountain, T Nobori, O I Olopade, G Robertson, D E Housman, T G Lugo.   

Abstract

Deletions of DNA on chromosome 9p21-22 are frequently observed in cells derived from melanomas, gliomas, non-small cell lung cancers, and acute lymphoblastic leukemia. The minimal deletion shared by the latter three cancers extends from the interferon-alpha locus towards the centromere; its centromeric end is flanked by the gene encoding methylthioadenosine phosphorylase. We have determined that the telomeric end of the minimal homozygous deletion shared by two melanoma cell lines does not include the methylthioadenosine phosphorylase locus. Thus, a distinct region of DNA is lost in melanoma. The physical size of this region remains to be defined precisely, but it may extend over several million base pairs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8275465

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  P16 deletion and mutation analysis in human brain tumors.

Authors:  F G Barker; P Chen; F Furman; K D Aldape; M S Edwards; M A Israel
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

Review 2.  Uncovering the immunotherapeutic cycle initiated by p19Arf and interferon-β gene transfer to cancer cells: An inducer of immunogenic cell death.

Authors:  Ruan F V Medrano; Aline Hunger; João P P Catani; Bryan E Strauss
Journal:  Oncoimmunology       Date:  2017-05-19       Impact factor: 8.110

3.  Loss of heterozygosity of microsatellite loci on chromosome 9p in astrocytic tumors and its prognostic implications.

Authors:  M Maruno; T Yoshimine; A K Muhammad; K Tokiyoshi; T Hayakawa
Journal:  J Neurooncol       Date:  1996-10       Impact factor: 4.130

4.  Recessive oncogenes: current status.

Authors:  Xiang Gao; Kenneth V Honn
Journal:  Pathol Oncol Res       Date:  1995       Impact factor: 3.201

5.  Identifying novel homozygous deletions by microsatellite analysis and characterization of tumor suppressor candidate 1 gene, TUSC1, on chromosome 9p in human lung cancer.

Authors:  Zhihong Shan; Tracy Parker; Jonathan S Wiest
Journal:  Oncogene       Date:  2004-08-26       Impact factor: 9.867

6.  Construction of a 2.8-megabase yeast artificial chromosome contig and cloning of the human methylthioadenosine phosphorylase gene from the tumor suppressor region on 9p21.

Authors:  O I Olopade; H M Pomykala; F Hagos; L W Sveen; R Espinosa; M H Dreyling; S Gursky; W M Stadler; M M Le Beau; S K Bohlander
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

7.  Measures for the degree of overlap of gene signatures and applications to TCGA.

Authors:  Xingjie Shi; Huangdi Yi; Shuangge Ma
Journal:  Brief Bioinform       Date:  2014-12-31       Impact factor: 13.994

8.  Loss of heterozygosity on chromosomes 3p,8p,9p and 17p in the progression of squamous cell carcinoma of the larynx.

Authors:  Woo Jeong Yoo; Seung Ho Cho; Youn Soo Lee; Gyeong Sin Park; Min Sik Kim; Byung Kee Kim; Won Sang Park; Jung Yong Lee; Chang Suk Kang
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

9.  TUSC1, a putative tumor suppressor gene, reduces tumor cell growth in vitro and tumor growth in vivo.

Authors:  Zhihong Shan; Abbas Shakoori; Sohrab Bodaghi; Paul Goldsmith; Jen Jin; Jonathan S Wiest
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

10.  Loss of heterozygosity at chromosome 9p in ductal carcinoma in situ and invasive carcinoma of the breast.

Authors:  K L Marsh; J M Varley
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.